Investments, deals and funding initiatives in nanotechnology. March-April 2017


BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of concussions and other acquired traumatic brain injuries, has closed a $2 million interim financing to support clinical development of the Tbit™ System, the first technology positioned to deliver a rapid and  objective point-of-care blood test for


You need to be a subscriber to Nanotech Magazine to view this page. If you are a member please log-in, if you are not and wish to view this content please go to